Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study

@article{Drks2013AntidepressantDU,
  title={Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study},
  author={Michael D{\"o}rks and Ingo Langner and Ulrich Dittmann and Antje Timmer and Edeltraut Garbe},
  journal={European Child \& Adolescent Psychiatry},
  year={2013},
  volume={22},
  pages={511-518}
}
The off-label use of drugs in children and adolescents is widespread. In Germany, the use of selective serotonin reuptake inhibitors (SSRIs) and other antidepressants (OADs) is not licensed for the treatment of depressive disorders in children and adolescents except for fluoxetine, which was approved in 2006. Against this background, antidepressant drug (ATD) use with a particular focus on off-label prescribing was characterised in a retrospective cohort study including cross-sectional analyses… 

Trends in Off‐Label Prescribing of Sedatives, Hypnotics and Antidepressants among Children and Adolescents – A Danish, Nationwide Register‐Based Study

TLDR
Off‐label rates for sedatives and hypnotics increased in the period of 2006–2012, whereas off‐ label rates for antidepressants declined, whereas the number of registered melatonin prescriptions increased expansively.

Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice

TLDR
Off-label use of antidepressants and antipsychotics in youth was not a risk factor for the occurrence of serious ADRs in a closely monitored clinical setting as evaluated in the ‘Therapeutic Drug Monitoring-VIGIL’ study.

Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database

TLDR
Antidepressant level of use in French children and adolescents was stable in recent years and lower than that observed in other European countries and the United States.

Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry

TLDR
A frequent use of off-label prescriptions when treating children and adolescents with psychopharmacological drugs other than ADHD medication is found, and prescription of more than 1 psychotropic drug is common.

Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study

TLDR
Antidepressant use in Germany varied considerably by age and sex and also on a state and district level and the most frequently prescribed drug class was tricyclic antidepressants whereas on a substance level citalopram was most commonly used.

Antidepressant prescribing in Irish children: secular trends and international comparison in the context of a safety warning

TLDR
The direction and timing of these trends suggest that medical practitioners followed the IMB advice and the prevalence of anti-depressants in Irish children was lower than the US, similar to the U.K. and higher than Germany and Denmark.

Outpatient antidepressant drug use in children and adolescents in Germany between 2004 and 2011

TLDR
Examining antidepressant use in pediatric patients aged 0 to 17 years over time, investigated changes regarding the prescribed drugs, analyzed underlying diagnoses, and assessed the rate of off‐label use.

Off-label prescribing of psychotropic drugs in a Danish child and adolescent psychiatric outpatient clinic

TLDR
It is revealed that medical treatment of children with other psychotropic drugs than ADHD drugs is usually off-label, and clinical trials in children should be incited.

Off-Label Prescribing of Antipsychotics in a Danish Child and Adolescent Mental Health Center: A Register-Based Study

TLDR
The prescribing patterns underpin the need for further economic incentives for pharmaceutical companies to register pediatric indications, particular for off-patent products.

References

SHOWING 1-10 OF 23 REFERENCES

Antidepressant use in children and adolescents in Germany.

TLDR
Prescription patterns in Germany reveal predominate use of St. John's Wort and TCAs in treatment of depression in children and adolescents in Germany, which contrasts sharply with U.S. patterns, wherein SSRIspredominate.

A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database

TLDR
SSRIs have gained popularity for the treatment of depression compared with TCAs, and TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents, with TCA users stopping earlier than SSRI users.

["Off-label" prescribing of drugs in the ambulatory care of children and adolescents].

TLDR
"Off-label" prescribing in outpatient children is less frequent than in pediatric inpatients, and doctors prescribing drugs for children and adolescents should be aware of their actual licensing status because of its medical and legal consequences.

Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001.

TLDR
The off-label use of antidepressant, anticonvulsant, and antipsychotic medications is highly prevalent among Georgia Medicaid recipients and further research to study the effects of off- label use among this high risk subpopulation may be an important step toward defining the scope of and potential for such use.

Antidepressant drug use: differences between psychiatrists and general practitioners. Results from a drug utilization observation study with fluoxetine.

TLDR
The findings reveal that-under routine conditions handled by PNs and GPIs-Fix shows an efficacy and safety consistent with clinical trial data.

Risk factors for unlicensed and off-label drug use in children outside the hospital.

TLDR
Efforts to improve pediatric labeling are important and need full support, and the present results can be used to focus these efforts.

Antidepressant use and off‐label prescribing in children and adolescents in Dutch general practice (2001–2005)

To study the use of antidepressants in children and adolescents in Dutch general practice in 2001 and 2005 and to determine off‐label prescribing.

„Off-label” Verschreibung von Arzneimitteln in der ambulanten Versorgung von Kindern und Jugendlichen

TLDR
"Off-label" prescribing in outpatient children is less frequent than in pediatric inpatients, and doctors prescribing drugs for children and adolescents should be aware of their actual licensing status because of its medical and legal consequences.

Patterns and prevalence of antidepressant drug use in the German state of Baden‐Wuerttemberg: a prescription‐based analysis

Population‐based data about patterns and prevalence of antidepressant drug use is limited in Europe and presently unavailable for Germany. Therefore, we have identified patterns and prevalence of

Representativity of dispensations of non-steroidal anti-inflammatory drugs (NSAIDs) in the German Pharmacoepidemiological Research Database

TLDR
Overall, data from GePaRD were sufficiently representative for Germany and enabled identification of changes in prescription patterns to a similar extent as the overall data from Germany, and some differences, especially regarding rarely prescribed drugs, need further examination.